These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

155 related articles for article (PubMed ID: 9175191)

  • 1. Representative payee practices of community mental health centers in Washington State.
    Ries RK; Dyck DG
    Psychiatr Serv; 1997 Jun; 48(6):811-4. PubMed ID: 9175191
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Managing disability benefits as part of treatment for persons with severe mental illness and comorbid drug/alcohol disorders. A comparative study of payee and non-payee participants.
    Ries RK; Comtois KA
    Am J Addict; 1997; 6(4):330-8. PubMed ID: 9398931
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Impact of representative payees on substance use by homeless persons with serious mental illness.
    Rosenheck R; Lam J; Randolph F
    Psychiatr Serv; 1997 Jun; 48(6):800-6. PubMed ID: 9175189
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Representative payee programs for persons with mental illness in Illinois.
    Hanrahan P; Luchins DJ; Savage C; Patrick G; Roberts D; Conrad KJ
    Psychiatr Serv; 2002 Feb; 53(2):190-4. PubMed ID: 11821550
    [TBL] [Abstract][Full Text] [Related]  

  • 5. An agency-based representative payee program and improved community tenure of persons with mental illness.
    Luchins DJ; Hanrahan P; Conrad KJ; Savage C; Matters MD; Shinderman M
    Psychiatr Serv; 1998 Sep; 49(9):1218-22. PubMed ID: 9735966
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Substance use and assignment of representative payees.
    Rosen MI; Rosenheck R
    Psychiatr Serv; 1999 Jan; 50(1):95-8. PubMed ID: 9890587
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Evaluating changes in symptoms and functioning of dually diagnosed clients in specialized treatment.
    Jerrell JM; Ridgely MS
    Psychiatr Serv; 1995 Mar; 46(3):233-8. PubMed ID: 7796208
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Does assigning a representative payee reduce substance abuse?
    Rosen MI; McMahon TJ; Rosenheck R
    Drug Alcohol Depend; 2007 Jan; 86(2-3):115-22. PubMed ID: 16839710
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Prospective study of favorable factors in follow-up of drug addicted patients--apropos of 257 patients of the Cassini Center in Paris].
    Goeb JL; Coste J; Bigot T; Ferrand I
    Encephale; 2000; 26(6):11-20. PubMed ID: 11217533
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Influence of retroactive disability payments on recipients' compliance with substance abuse treatment.
    Satel S; Reuter P; Hartley D; Rosenheck R; Mintz J
    Psychiatr Serv; 1997 Jun; 48(6):796-9. PubMed ID: 9175188
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Substance abuse and the need for money management assistance among psychiatric inpatients.
    Rosen MI; Rosenheck RA; Shaner AL; Eckman TA; Gamache GR; Krebs CW
    Drug Alcohol Depend; 2002 Aug; 67(3):331-4. PubMed ID: 12127204
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Is addiction an illness--can it be treated?
    McLellan AT
    Subst Abus; 2002 Sep; 23(3 Suppl):67-94. PubMed ID: 23580988
    [No Abstract]   [Full Text] [Related]  

  • 13. Psychotherapy with dual diagnosis patients: working with denial.
    Levy M
    J Subst Abuse Treat; 1993; 10(6):499-504. PubMed ID: 8308933
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Financial Capability: Clinicians' Assessment of Beneficiaries With Dual Diagnoses.
    Thornhill Iv TA; Black AC; Rosen MI
    J Dual Diagn; 2018; 14(2):130-136. PubMed ID: 29505348
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Disability payments and chemical dependence: conflicting values and uncertain effects.
    Rosenheck R
    Psychiatr Serv; 1997 Jun; 48(6):789-91. PubMed ID: 9175186
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Veterans who may need a payee to prevent misuse of funds for drugs.
    Rosen MI; Rosenheck RA; Shaner A; Eckman T; Gamache G; Krebs C
    Psychiatr Serv; 2002 Aug; 53(8):995-1000. PubMed ID: 12161675
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Cost-effectiveness of assertive community treatment versus standard case management for persons with co-occurring severe mental illness and substance use disorders.
    Clark RE; Teague GB; Ricketts SK; Bush PW; Xie H; McGuire TG; Drake RE; McHugo GJ; Keller AM; Zubkoff M
    Health Serv Res; 1998 Dec; 33(5 Pt 1):1285-308. PubMed ID: 9865221
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Case managers' and clients' perspectives on a representative payee program.
    Dixon L; Turner J; Krauss N; Scott J; McNary S
    Psychiatr Serv; 1999 Jun; 50(6):781-6. PubMed ID: 10375147
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Randomized controlled trial of contingency management for stimulant use in community mental health patients with serious mental illness.
    McDonell MG; Srebnik D; Angelo F; McPherson S; Lowe JM; Sugar A; Short RA; Roll JM; Ries RK
    Am J Psychiatry; 2013 Jan; 170(1):94-101. PubMed ID: 23138961
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Pharmacotherapeutic management strategies for mentally ill substance abusers.
    Adelman SA; Fletcher KE; Bahnassi A
    J Subst Abuse Treat; 1993; 10(4):353-8. PubMed ID: 8411295
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.